About

At J&J, we are leading where medicine is going. Patients will always inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we will continue to confidently address the most complex diseases of our time and unlock the potential medicines of tomorrow.

Address

Leoforos Irinis 56, 15121, Pefki

Contact details

Medical Information phone number
+30 210 809 0728

Hours of operation
Mon - Fri 9AM - 5PM EET except bank holidays

Medical Information email
medinfogr@its.jnj.com

Adverse events and product complaints

Please use the contact details below to report adverse events or product complaints

Adverse event phone number
+30 210 809 0640

Adverse event email
farmaco@its.jnj.com

J&J products

Medicinal products marked withare subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z

Akeega
(Niraparib, Abiraterone acetate)

Carvykti
(Ciltacabtagene autoleucel)

Darzalex
(Daratumumab)

Erleada
(Apalutamide)

Imbruvica
(Ibrutinib)

Opsumit
(Macitentan)

Rybrevant
(Amivantamab)

Spravato
(Esketamine)

Stelara
(Ustekinumab)

Talvey
(Talquetamab)

Tecvayli
(Teclistamab)

Tremfya
(Guselkumab)

Trevicta
(Paliperidone Palmitate)

Uptravi
(Selexipag)

Xeplion
(Paliperidone Palmitate)

Zytiga
(Abiraterone Acetate)

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z
Page last updated: 02/07/2024